ARTICLE | Distillery Therapeutics
Infectious disease
February 28, 2019 9:11 PM UTC
Cell culture and mouse studies identified a deoxystreptamine-based inhibitor of the ribosomal 30S subunit that could help treat E. coli and other Gram-negative bacterial infections. Chemical synthesis...
BCIQ Target Profiles